Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Racial differences in prostate cancer related to loss of heterozygosity on chromosome 8p12-23.

Kalapurakal JA, Jacob AN, Kim PY, Najjar DD, Hsieh YC, Ginsberg P, Daskal I, Asbell SO, Kandpal RP.

Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):835-40.

PMID:
10571186
2.

Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.

Lee LN, Barnswell C, Torre T, Fearn P, Kattan M, Potters L.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):282-9.

PMID:
12023131
3.

8pter-p23 deletion is associated with racial differences in prostate cancer outcome.

Washburn JG, Wojno KJ, Dey J, Powell IJ, Macoska JA.

Clin Cancer Res. 2000 Dec;6(12):4647-52.

4.

Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.

Fromont G, Valeri A, Cher M, Pontes JE, Vallancien G, Validire P, Latil A, Cussenot O.

Prostate. 2005 Dec 1;65(4):341-6.

PMID:
16015610
5.

Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.

Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM.

Cancer Res. 1996 May 15;56(10):2411-6.

6.
7.

Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer.

Perinchery G, Bukurov N, Nakajima K, Chang J, Hooda M, Oh BR, Dahiya R.

Int J Oncol. 1999 Mar;14(3):495-500.

PMID:
10024682
8.

Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.

Eastham JA, Carver B, Katz J, Kattan MW.

Prostate. 2002 Mar 1;50(4):236-40.

PMID:
11870801
9.

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ.

Urology. 2000 Jul;56(1):87-91.

PMID:
10869631
10.

Counting alleles in single lesions of prostate tumors from ethnically diverse patients.

Morikawa A, Varma V, Gillespie TW, Lyles RH, Goodman M, Bostick RM, Mandel JS, Zhou W.

Prostate. 2008 Feb 15;68(3):231-40.

PMID:
18092351
11.

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Freedland SJ, Amling CL, Dorey F, Kane CJ, Presti JC Jr, Terris MK, Aronson WJ; Shared Equal Access Regional Cancer Hospital Database Study Group.

Urology. 2002 Oct;60(4):670-4.

PMID:
12385931
12.

Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.

Abdalla I, Ray P, Vaida F, Vijayakumar S.

Am J Clin Oncol. 1999 Dec;22(6):537-41.

PMID:
10597735
13.

Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.

Latini JM, Rieger-Christ KM, Wang DS, Silverman ML, Libertino JA, Summerhayes IC.

J Urol. 2001 Nov;166(5):1931-6.

PMID:
11586263
14.

The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.

Pan CC, Lee JS, Chan JL, Sandler HM, Underwood W, McLaughlin PW.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1292-6.

PMID:
14630264
15.
16.

Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients.

Guo Y, Sigman DB, Borkowski A, Kyprianou N.

Prostate. 2000 Feb 1;42(2):130-6.

PMID:
10617870
17.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

18.

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.

Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, Awan AM.

Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec;1(7):541-5.

19.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
20.

Allelic losses in localized prostate cancer: association with prognostic factors.

Fromont G, Joulin V, Chantrel-Groussard K, Vallancien G, Guillonneau B, Validire P, Latil A, Cussenot O.

J Urol. 2003 Oct;170(4 Pt 1):1394-7.

PMID:
14501776
Items per page

Supplemental Content

Write to the Help Desk